These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28686985)

  • 1. Somatic health care utilization by patients treated for substance use disorders.
    de Weert-van Oene GH; Termorshuizen F; Buwalda VJA; Heerdink ER
    Drug Alcohol Depend; 2017 Sep; 178():277-284. PubMed ID: 28686985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability and predictors of treatment-seeking for substance use disorders in the U.S.
    Blanco C; Iza M; Rodríguez-Fernández JM; Baca-García E; Wang S; Olfson M
    Drug Alcohol Depend; 2015 Apr; 149():136-44. PubMed ID: 25725934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders.
    Frasch K; Larsen JI; Cordes J; Jacobsen B; Wallenstein Jensen SO; Lauber C; Nielsen JA; Tsuchiya KJ; Uwakwe R; Munk-Jørgensen P; Kilian R; Becker T
    Int J Soc Psychiatry; 2013 Dec; 59(8):757-64. PubMed ID: 23034284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.
    Evans E; Padwa H; Li L; Lin V; Hser YI
    J Subst Abuse Treat; 2015 Dec; 59():10-9. PubMed ID: 26321439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.
    Haughwout SP; Harford TC; Castle IJ; Grant BF
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1717-27. PubMed ID: 27427179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health insurance and treatment of adolescents with co-occurring major depression and substance use disorders.
    Dicola LA; Gaydos LM; Druss BG; Cummings JR
    J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):953-60. PubMed ID: 23972697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis.
    Carrà G; Bartoli F; Crocamo C; Brady KT; Clerici M
    J Affect Disord; 2014; 167():125-35. PubMed ID: 24955564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of injury with substance use disorder among women of reproductive age: an opportunity to address a major contributor to recurrent preventable emergency department visits?
    Bernstein J; Bernstein E; Belanoff C; Cabral HJ; Babakhanlou-Chase H; Derrington TM; Diop H; Douriez C; Evans SR; Jacobs H; Kotelchuck M
    Acad Emerg Med; 2014 Dec; 21(12):1459-68. PubMed ID: 25491709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.
    Matthews AM; Huckans MS; Blackwell AD; Hauser P
    Bipolar Disord; 2008 Mar; 10(2):266-70. PubMed ID: 18271905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders.
    Tate SR; Brown SA; Unrod M; Ramo DE
    Addict Behav; 2004 Dec; 29(9):1707-24. PubMed ID: 15530716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population.
    Blom RM; Koeter M; van den Brink W; de Graaf R; Ten Have M; Denys D
    Addiction; 2011 Dec; 106(12):2178-85. PubMed ID: 21714825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course, remission and recovery in patients with severe psychotic disorders with or without comorbid substance use disorders: Long-term outcome in evidence-based integrated care (ACCESS II study).
    Ruppelt F; Rohenkohl A; Kraft V; Schöttle D; Schröter R; Gaianigo J; Werkle N; Daubmann A; Karow A; Lambert M
    Schizophr Res; 2020 Aug; 222():437-443. PubMed ID: 32507378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment.
    Hagedorn HJ; Noorbaloochi S; Bangerter A; Stitzer ML; Kivlahan D
    J Subst Abuse Treat; 2017 Aug; 79():46-52. PubMed ID: 28673526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.
    Davis AK; Rosenberg H; Rosansky JA
    J Subst Abuse Treat; 2017 Nov; 82():29-33. PubMed ID: 29021112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.